Investigation of the Human Immune Response in Normal Subjects and Patients With Disorders of the Immune System and Cancer
CompletedOBSERVATIONAL
Enrollment
902
Participants
Timeline
Start Date
June 7, 1997
Primary Completion Date
March 17, 2023
Study Completion Date
March 17, 2023
Conditions
T-cell LymphomaB-Cell LymphomaATLMyeloma
Trial Locations (1)
20892
National Institutes of Health Clinical Center, Bethesda
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00001582 - Investigation of the Human Immune Response in Normal Subjects and Patients With Disorders of the Immune System and Cancer | Biotech Hunter | Biotech Hunter